Esther Llagostera

The prodigiosins, proapoptotic drugs with anticancer properties.

V. Soto-Cerrato, R. Pérez-Tomás, B. Montaner, 2003, Biochemical pharmacology.

High cytotoxic sensitivity of the human small cell lung doxorubicin-resistant carcinoma (GLC4/ADR) cell line to prodigiosin through apoptosis activation

P. Gimenez-Bonafe, V. Soto-Cerrato, R. Pérez-Tomás, 2005, Anti-cancer drugs.

Mitochondria-mediated apoptosis operating irrespective of multidrug resistance in breast cancer cells by the anticancer agent prodigiosin.

V. Soto-Cerrato, R. Pérez-Tomás, G. Scheffer, 2004, Biochemical pharmacology.

Prodigiosin Induces Apoptosis by Acting on Mitochondria in Human Lung Cancer Cells

V. Soto-Cerrato, R. Pérez-Tomás, B. Montaner, 2003, Annals of the New York Academy of Sciences.

Role of Myotonic Dystrophy Protein Kinase (DMPK) in Glucose Homeostasis and Muscle Insulin Action

D. Catalucci, M. Palacín, A. Zorzano, 2007, PloS one.

Altered β‐adrenergic response in mice lacking myotonic dystrophy protein kinase

D. Catalucci, P. Kaliman, M. Párrizas, 2012, Muscle & nerve.

Novel mechanisms in the development of insulin resistance and new therapeutic strategies for diabetes

Jéssica, Víctor A. Francis, M. Liesa, 2022 .

Myotonic dystrophy protein kinase (DMPK) and its role in the pathogenesis of myotonic dystrophy 1.

P. Kaliman, Esther Llagostera, 2008, Cellular signalling.

High‐fat diet induced adiposity and insulin resistance in mice lacking the myotonic dystrophy protein kinase

P. Kaliman, R. M. Escorihuela, M. Carmona, 2009, FEBS letters.